Clinical Trials

Showing trials with last updates posted in 2024.

NCT02249000 | COMPLETED | NA
68 participants

BIOVALVE - I / II Clincial Investigation

Study Type:
INTERVENTIONAL
Last Updated:
2024-06-11
Start Date:
2014-09-30
Completion:
2018-03-31
Conditions
  • Heart Valve Diseases
  • Aortic Valve Stenosis
Interventions
  • DEVICE
No Results Yet
NCT02199184 | COMPLETED | PHASE2
14 participants

Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2024-06-11
Start Date:
2015-01-14
Completion:
2023-02-17
Conditions
  • AIDS-Related Burkitt Lymphoma
  • Atypical Burkitt/Burkitt-Like Lymphoma
  • High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Burkitt Lymphoma
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Burkitt Lymphoma
Interventions
  • DRUG
  • BIOLOGICAL
NCT06450652 | NOT_YET_RECRUITING | NA
15 participants

CHM for T2DM & MetS

Study Type:
INTERVENTIONAL
Last Updated:
2024-06-10
Start Date:
2024-06-30
Completion:
2024-09-30
Conditions
  • Type 2 Diabetes Mellitus With Metabolic Syndrome
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page